Decheng Capital Management III as of March 31, 2023
Portfolio Holdings for Decheng Capital Management III
Decheng Capital Management III holds 24 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alabama Power Co. p | 20.9 | $52M | 6.7M | 7.72 | |
| Zentalis Pharmaceuticals (ZNTL) | 12.7 | $31M | 1.8M | 17.20 | |
| 10x Genomics Cl A Com (TXG) | 8.1 | $20M | 360k | 55.79 | |
| Illumina (ILMN) | 7.6 | $19M | 81k | 232.55 | |
| Pacific Biosciences of California (PACB) | 6.8 | $17M | 1.5M | 11.58 | |
| Cue Health (HLTHQ) | 6.6 | $16M | 9.0M | 1.82 | |
| Prometheus Biosciences | 6.5 | $16M | 150k | 107.32 | |
| Arcus Biosciences Incorporated (RCUS) | 6.4 | $16M | 870k | 18.24 | |
| Argenx SE SHS (ARGX) | 4.1 | $10M | 27k | 372.58 | |
| Horizon Therapeutics | 3.5 | $8.6M | 79k | 109.14 | |
| Terns Pharmaceuticals (TERN) | 3.4 | $8.5M | 714k | 11.84 | |
| BeyondSpring SHS (BYSI) | 2.2 | $5.6M | 5.0M | 1.12 | |
| Seattle Genetics | 1.9 | $4.7M | 23k | 202.47 | |
| Aadi Bioscience (AADI) | 1.5 | $3.8M | 526k | 7.24 | |
| Mersana Therapeutics (MRSN) | 1.5 | $3.7M | 904k | 4.11 | |
| Adicet Bio (ACET) | 1.3 | $3.3M | 580k | 5.76 | |
| Equillium (EQ) | 1.3 | $3.2M | 4.4M | 0.73 | |
| Aura Biosciences (AURA) | 1.1 | $2.7M | 293k | 9.28 | |
| AtriCure (ATRC) | 0.8 | $1.9M | 46k | 41.45 | |
| Scynexis Com New (SCYX) | 0.7 | $1.7M | 556k | 3.00 | |
| GeneDx Holdings Corp. Com Cl A | 0.5 | $1.2M | 3.4M | 0.36 | |
| Apexigen | 0.4 | $923k | 1.9M | 0.49 | |
| Owlet Com Cl A | 0.1 | $291k | 898k | 0.32 | |
| Neubase Therapeutics Ord | 0.1 | $185k | 1.0M | 0.18 |
